2010 Annual Scientific Meeting and Exposition 2010 Annual ...

Monday Morning Afternoon May 213Posters Late-Breaking PostersLB-PO-08:LB-PO-09:LB-PO-10:LB-PO-12:LB-PO-13:LB-PO-14:Effects on BP Control Of Amlodipine (AML)/Olmesartan Medoxomil (OM), with or withoutHydrochlorothiazide (HCTZ), in Patients NotControlled by Prior Antihypertensive MonotherapyM. Weir†, 1 W. Hseuh, 2 S. Nesbitt, 3 M. Weber, 4 T.Littlejohn, 5 A. Graff, 6 A. Shojaee, 7 W. Waverczak, 7 C.Qian, 7 C. Jones, 8 J. Neutel. 9 1 University of MarylandSchool of Medicine, US; 2 The Methodist HospitalResearch Institute, US; 3 UT Southwestern MedicalCenter, US; 4 SUNY Downstate Medical CenterCollege of Medicine, US; 5 Piedmont Medical ResearchAssociates, US; 6 Private Practice, US; 7 Daiichi Sankyo,Inc., US; 8 Wolters Kluwer, US and 9 Orange CountyResearch Center, US.Efficacy and Safety of Nebivolol Monotherapy inHispanics with Stage I-II HypertensionHenry A. Punzi, 1 Andrew J. Lewin, 2 Tanya Lukic, 3Thomas Goodin, 3 Wei Chen. 3 1 Trinity HypertensionResearch Institute, Carrollton, TX, US; 2 NationalResearch Institute, Los Angeles, CA, US and 3 ForestResearch Institute, Jersey City, NJ, US.Single-Pill Combination of Telmisartan 80 Mg/Amlodipine 10 Mg Provides Superior Blood-Pressure Reductions in Patients with SevereHypertension: TEAMSTA Severe Htn StudyJoel M. Neutel†, 1 Giuseppe Mancia, 2 Henry R. Black, 3Björn Dahlöf, 4 Holly Defeo, 5 Ludwin Ley, 6 RichardVinisko. 5 1 Orange County Research Center, US;2 University of Milano-Bicocca, San Gerardo Hospital,IT; 3 New York University School of Medicine,US; 4 Sahlgrenska University Hospital/Östra, SE;5 Boehringer Ingelheim Pharmaceuticals Inc, US and6 Boehringer Ingelheim GmbH & Co. KG, DE.ISHIB IMPACT CV RISK Reduction ToolkitResearch Study: Study DesignElijah Saunders, 1 Bessie M. B. Weaver, 1 Keith C.Ferdinand, 2 Kenneth A. Jamerson. 3 1 University ofMaryland School of Medicine, Baltimore, MD, US;2 Association Black Cardiologists, Inc, Atlanta, GA,US and 3 University of Michigan Health System, AnnArbor, MI, US.Differential Changes in RAS Genes and BloodPressure by High Na-Intake in Lean and ObeseZucker RatsPreethi Samuel, Quaisar Ali, Rifat Sabuhi, TahirHussain. University of Houston, Houston, TX, US.Chronic Treatment with AT2 Receptor AgonistCGP42112A Lowers Renal Renin Expression andDecreases Blood Pressure in Obese Zucker RatsQuaisar Ali†, Preethi Samuel, Rifat Sabuhi, TahirHussain. Heart and Kidney Institute, College ofPharmacy, Houston, TX, US.1 Pathobiology Track 2 Translational Track 3 Therapy Track159